Remove Doctors Remove Government Remove Licensing
article thumbnail

Operation Warp Speed’s top doctor says coronavirus vaccine likely won’t be approved until after November

The Pharma Data

Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the US will be ready by November. . The government wants to vaccinate the elderly and people with underlying conditions first. Air Force photo/Senior Airman Areca T.

Doctors 52
article thumbnail

Coronavirus: Health workers' army to be trained to deliver Covid vaccine

The Pharma Data

The government plans to train up an army of health professionals to be ready to give the coronavirus vaccine, if and when one is shown to work. The Department of Health and Social Care (DHSC) said this could include training a wider range of existing NHS staff, as well as student doctors and nurses. Image copyright. Getty Images.

Vaccine 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Coronavirus antibodies tests 'put public at risk'

The Pharma Data

Poor regulation of antibodies tests – that could indicate if someone has had coronavirus – could be putting the public at risk, doctors have warned. “For drug licensing the onus is on the companies to go through clinical trials. Across government, action is being taken to enforce these tough regulations.

article thumbnail

Dr. Kent R. Van Kampen Celebrated for Dedication to the Field of Pharmaceutical Research

The Pharma Data

Drawing upon 50 years of expertise in clinical research, biopharmaceuticals, biotechnology and drug discovery, Dr. Van Kampen excels as the chief executive officer of The Van Kampen Group, which assists other companies in research and liaisons with government and industry regarding licensing products for commercial use.

article thumbnail

Health Care After COVID: The Rise of Telemedicine

The Pharma Data

That’s just one example of how doctors are using telemedicine – having appointments by phone or video call – to check in with their patients. And even when doctors’ offices were open, some patients avoided in-person appointments due to COVID-19 fears. “We think that telehealth is here to stay.

Doctors 52
article thumbnail

The Pharma Data - Untitled Article

The Pharma Data

SK bioscience and GSK announced submission of a biologics license application for SKYCovione™ a recombinant protein-based COVID-19 vaccine candidate adjuvanted with GSK’s pandemic adjuvant, to the Korean Ministry of Food and Drug Safety (KMFDS) following positive Phase III clinical data.

article thumbnail

RECOVERY Trial Data Monitoring Committee Recommends Continuing Evaluation of REGN-COV2 in All Hospitalized Patients

The Pharma Data

The trial is supported by a grant to the University of Oxford from UK Research and Innovation / National Institute for Health Research (NIHR) and by core funding provided by NIHR Oxford Biomedical Research Centre , Wellcome , the Bill and Melinda Gates Foundation , the Department for International Development , Health Data Research UK , the (..)